Dr. Kuerer on Margins of DCIS

Henry M. Kuerer, MD, PhD
Published: Wednesday, Aug 09, 2017



Henry M. Kuerer, MD, PhD, professor of surgery, The University of Texas MD Anderson Cancer Center, discusses margins of ductal carcinoma in situ (DCIS).

National guidelines for invasive breast cancer has resulted in decreased rates of mastectomy, explains Kuerer. Physicians are still unsure as to how there can be a different margin of criteria for DCIS versus invasive breast cancer with DCIS, especially when patients are receiving postoperative radiotherapy.

There are data suggesting that there is multifocality related to DCIS but the same criteria applies when DCIS accompanies the invasive breast cancer, states Kuerer.
 


Henry M. Kuerer, MD, PhD, professor of surgery, The University of Texas MD Anderson Cancer Center, discusses margins of ductal carcinoma in situ (DCIS).

National guidelines for invasive breast cancer has resulted in decreased rates of mastectomy, explains Kuerer. Physicians are still unsure as to how there can be a different margin of criteria for DCIS versus invasive breast cancer with DCIS, especially when patients are receiving postoperative radiotherapy.

There are data suggesting that there is multifocality related to DCIS but the same criteria applies when DCIS accompanies the invasive breast cancer, states Kuerer.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x